Q-linea AB (OSTO:QLINEA) Notes Receivable: kr0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:QLINEA Q-linea AB OSTO:QLINEA
67 GF Score
Price kr16.75
GF Value kr19.72
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Notes Receivable?

Q-linea AB OSTO:QLINEA +0.30% 67 Notes Receivable is kr0.00 Mil as of Jun. 2026. GuruFocus rates OSTO:QLINEA with a GF Score™ of 67/100 and a GF Value™ of kr19.72 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Q-linea AB's Notes Receivable for the quarter that ended in Jun. 2026 was kr0.00 Mil.

Q-linea AB Notes Receivable Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Notes Receivable Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Q-linea AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:QLINEA
67GF Score
Q-linea AB OSTO:QLINEA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0.00 Mil mean?
Q-linea AB (OSTO:QLINEA) has a Notes Receivable of kr0.00 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Q-linea AB and its competitors.
Is Q-linea AB's Notes Receivable too high?
Q-linea AB's current Notes Receivable is kr0.00 Mil. Overall, Q-linea AB has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Notes Receivable compare to ABT and SYK?
Q-linea AB's Notes Receivable of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Q-linea AB and its competitors. Q-linea AB's current Notes Receivable is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Based on GuruFocus' analysis, Q-linea AB (OSTO:QLINEA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr19.72, compared to a current price of kr16.75 — trading 15.1% below its estimated fair value. The current Notes Receivable is kr0.00 Mil. Q-linea AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Q-linea AB (OSTO:QLINEA), the current Notes Receivable is kr0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (OSTO:QLINEA) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr16.75 is trading 15.1% below its estimated GF Value™ of kr19.72. GuruFocus considers Q-linea AB to be Modestly Undervalued.

Key valuation signals for OSTO:QLINEA:

  • Notes Receivable: kr0.00 Mil
  • GF Value™: kr19.72 vs. price of kr16.75 (15.1% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the OSTO:QLINEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges 3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
67GF Score

Get the complete analysis for OSTO:QLINEA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr16.75
Price
kr19.72
GF Value